nodes	percent_of_prediction	percent_of_DWPC	metapath
Melphalan—peripheral nervous system neoplasm—head and neck cancer	0.87	1	CtDrD
Melphalan—Ureteric obstruction—Hydroxyurea—head and neck cancer	0.00717	0.0645	CcSEcCtD
Melphalan—Leukaemia—Hydroxyurea—head and neck cancer	0.00437	0.0393	CcSEcCtD
Melphalan—Skin necrosis—Hydroxyurea—head and neck cancer	0.00337	0.0303	CcSEcCtD
Melphalan—Myelosuppression—Vinblastine—head and neck cancer	0.00275	0.0247	CcSEcCtD
Melphalan—Pulmonary fibrosis—Hydroxyurea—head and neck cancer	0.00268	0.0241	CcSEcCtD
Melphalan—Myelosuppression—Hydroxyurea—head and neck cancer	0.00251	0.0226	CcSEcCtD
Melphalan—Cutaneous hypersensitivity—Docetaxel—head and neck cancer	0.0025	0.0225	CcSEcCtD
Melphalan—Acute leukaemia—Docetaxel—head and neck cancer	0.00214	0.0192	CcSEcCtD
Melphalan—Febrile neutropenia—Hydroxyurea—head and neck cancer	0.00196	0.0176	CcSEcCtD
Melphalan—SLC22A3—tongue—head and neck cancer	0.00192	0.116	CbGeAlD
Melphalan—Myelosuppression—Fluorouracil—head and neck cancer	0.00181	0.0162	CcSEcCtD
Melphalan—Digestion impaired—Hydroxyurea—head and neck cancer	0.00176	0.0158	CcSEcCtD
Melphalan—Bone marrow depression—Hydroxyurea—head and neck cancer	0.00174	0.0157	CcSEcCtD
Melphalan—Local reaction—Fluorouracil—head and neck cancer	0.00153	0.0138	CcSEcCtD
Melphalan—Skin ulcer—Hydroxyurea—head and neck cancer	0.00151	0.0136	CcSEcCtD
Melphalan—Ibuprofen—BCL2—head and neck cancer	0.00149	0.811	CrCbGaD
Melphalan—Extravasation—Vinblastine—head and neck cancer	0.00148	0.0133	CcSEcCtD
Melphalan—SLC7A5—parotid gland—head and neck cancer	0.00145	0.0877	CbGeAlD
Melphalan—Febrile neutropenia—Fluorouracil—head and neck cancer	0.00141	0.0127	CcSEcCtD
Melphalan—Pulmonary fibrosis—Docetaxel—head and neck cancer	0.00139	0.0125	CcSEcCtD
Melphalan—SLC7A5—saliva-secreting gland—head and neck cancer	0.00139	0.084	CbGeAlD
Melphalan—Amenorrhoea—Hydroxyurea—head and neck cancer	0.00134	0.012	CcSEcCtD
Melphalan—Myelosuppression—Docetaxel—head and neck cancer	0.0013	0.0117	CcSEcCtD
Melphalan—SLC22A3—mouth—head and neck cancer	0.00129	0.0781	CbGeAlD
Melphalan—SLC7A5—connective tissue—head and neck cancer	0.00127	0.0771	CbGeAlD
Melphalan—Hyperuricaemia—Hydroxyurea—head and neck cancer	0.00127	0.0114	CcSEcCtD
Melphalan—Interstitial pneumonia—Docetaxel—head and neck cancer	0.00127	0.0114	CcSEcCtD
Melphalan—Ulcer—Hydroxyurea—head and neck cancer	0.00124	0.0112	CcSEcCtD
Melphalan—SLC7A5—epithelium—head and neck cancer	0.00121	0.0732	CbGeAlD
Melphalan—Blood uric acid increased—Hydroxyurea—head and neck cancer	0.0012	0.0108	CcSEcCtD
Melphalan—Neoplasm—Vinblastine—head and neck cancer	0.00117	0.0105	CcSEcCtD
Melphalan—Skin exfoliation—Hydroxyurea—head and neck cancer	0.00112	0.0101	CcSEcCtD
Melphalan—Foetor hepaticus—Docetaxel—head and neck cancer	0.00108	0.00969	CcSEcCtD
Melphalan—SLC7A5—trachea—head and neck cancer	0.00107	0.0648	CbGeAlD
Melphalan—Neoplasm—Hydroxyurea—head and neck cancer	0.00106	0.00957	CcSEcCtD
Melphalan—Tingling sensation—Fluorouracil—head and neck cancer	0.00105	0.00947	CcSEcCtD
Melphalan—Febrile neutropenia—Docetaxel—head and neck cancer	0.00102	0.00914	CcSEcCtD
Melphalan—Extravasation—Fluorouracil—head and neck cancer	0.000971	0.00873	CcSEcCtD
Melphalan—SLC7A5—lymphoid tissue—head and neck cancer	0.000931	0.0564	CbGeAlD
Melphalan—Renal failure acute—Hydroxyurea—head and neck cancer	0.000925	0.00832	CcSEcCtD
Melphalan—SLC22A3—parotid gland—head and neck cancer	0.000898	0.0544	CbGeAlD
Melphalan—Liver disorder—Docetaxel—head and neck cancer	0.000897	0.00806	CcSEcCtD
Melphalan—Ulcer—Fluorouracil—head and neck cancer	0.000896	0.00805	CcSEcCtD
Melphalan—Interstitial lung disease—Docetaxel—head and neck cancer	0.000864	0.00777	CcSEcCtD
Melphalan—SLC22A3—saliva-secreting gland—head and neck cancer	0.00086	0.0521	CbGeAlD
Melphalan—SLC7A5—thyroid gland—head and neck cancer	0.000845	0.0512	CbGeAlD
Melphalan—Dermatitis atopic—Docetaxel—head and neck cancer	0.000826	0.00743	CcSEcCtD
Melphalan—SLC22A3—connective tissue—head and neck cancer	0.00079	0.0479	CbGeAlD
Melphalan—Pancytopenia—Vinblastine—head and neck cancer	0.000769	0.00691	CcSEcCtD
Melphalan—SLC7A5—head—head and neck cancer	0.00075	0.0455	CbGeAlD
Melphalan—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000708	0.00636	CcSEcCtD
Melphalan—Pancytopenia—Hydroxyurea—head and neck cancer	0.000701	0.0063	CcSEcCtD
Melphalan—Extravasation—Docetaxel—head and neck cancer	0.000701	0.0063	CcSEcCtD
Melphalan—Amenorrhoea—Docetaxel—head and neck cancer	0.000696	0.00626	CcSEcCtD
Melphalan—Neutropenia—Hydroxyurea—head and neck cancer	0.00069	0.00621	CcSEcCtD
Melphalan—Haemoglobin—Vinblastine—head and neck cancer	0.000651	0.00586	CcSEcCtD
Melphalan—Haemorrhage—Vinblastine—head and neck cancer	0.000648	0.00583	CcSEcCtD
Melphalan—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000645	0.0058	CcSEcCtD
Melphalan—Stomatitis—Hydroxyurea—head and neck cancer	0.000642	0.00577	CcSEcCtD
Melphalan—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000623	0.0056	CcSEcCtD
Melphalan—Hepatocellular injury—Docetaxel—head and neck cancer	0.000611	0.0055	CcSEcCtD
Melphalan—Injection site reaction—Docetaxel—head and neck cancer	0.000608	0.00546	CcSEcCtD
Melphalan—Haemoglobin—Hydroxyurea—head and neck cancer	0.000594	0.00534	CcSEcCtD
Melphalan—Haemorrhage—Hydroxyurea—head and neck cancer	0.000591	0.00531	CcSEcCtD
Melphalan—Cardiac arrest—Fluorouracil—head and neck cancer	0.000585	0.00526	CcSEcCtD
Melphalan—Skin exfoliation—Docetaxel—head and neck cancer	0.000584	0.00525	CcSEcCtD
Melphalan—Neuropathy—Docetaxel—head and neck cancer	0.000574	0.00516	CcSEcCtD
Melphalan—Alopecia—Vinblastine—head and neck cancer	0.000573	0.00515	CcSEcCtD
Melphalan—Neoplasm—Docetaxel—head and neck cancer	0.000553	0.00497	CcSEcCtD
Melphalan—SLC7A5—lymph node—head and neck cancer	0.000525	0.0318	CbGeAlD
Melphalan—SLC22A3—thyroid gland—head and neck cancer	0.000525	0.0318	CbGeAlD
Melphalan—Alopecia—Hydroxyurea—head and neck cancer	0.000522	0.0047	CcSEcCtD
Melphalan—Anaemia—Vinblastine—head and neck cancer	0.000521	0.00469	CcSEcCtD
Melphalan—Leukopenia—Vinblastine—head and neck cancer	0.000505	0.00454	CcSEcCtD
Melphalan—Pancytopenia—Fluorouracil—head and neck cancer	0.000505	0.00454	CcSEcCtD
Melphalan—Convulsion—Vinblastine—head and neck cancer	0.000489	0.00439	CcSEcCtD
Melphalan—Anaemia—Hydroxyurea—head and neck cancer	0.000476	0.00428	CcSEcCtD
Melphalan—Atrial fibrillation—Docetaxel—head and neck cancer	0.000468	0.00421	CcSEcCtD
Melphalan—SLC22A3—head—head and neck cancer	0.000466	0.0282	CbGeAlD
Melphalan—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000465	0.00418	CcSEcCtD
Melphalan—Stomatitis—Fluorouracil—head and neck cancer	0.000462	0.00415	CcSEcCtD
Melphalan—Leukopenia—Hydroxyurea—head and neck cancer	0.000461	0.00414	CcSEcCtD
Melphalan—Thrombocytopenia—Vinblastine—head and neck cancer	0.000451	0.00405	CcSEcCtD
Melphalan—Convulsion—Hydroxyurea—head and neck cancer	0.000446	0.00401	CcSEcCtD
Melphalan—Hyponatraemia—Docetaxel—head and neck cancer	0.000446	0.00401	CcSEcCtD
Melphalan—Anorexia—Vinblastine—head and neck cancer	0.000439	0.00395	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000435	0.00391	CcSEcCtD
Melphalan—Haemoglobin—Fluorouracil—head and neck cancer	0.000428	0.00384	CcSEcCtD
Melphalan—Haemorrhage—Fluorouracil—head and neck cancer	0.000425	0.00382	CcSEcCtD
Melphalan—Oedema—Hydroxyurea—head and neck cancer	0.00042	0.00378	CcSEcCtD
Melphalan—Infection—Hydroxyurea—head and neck cancer	0.000417	0.00375	CcSEcCtD
Melphalan—Paraesthesia—Vinblastine—head and neck cancer	0.000413	0.00372	CcSEcCtD
Melphalan—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000411	0.0037	CcSEcCtD
Melphalan—Liver function test abnormal—Docetaxel—head and neck cancer	0.00041	0.00368	CcSEcCtD
Melphalan—Skin disorder—Hydroxyurea—head and neck cancer	0.000408	0.00367	CcSEcCtD
Melphalan—Anorexia—Hydroxyurea—head and neck cancer	0.0004	0.0036	CcSEcCtD
Melphalan—Decreased appetite—Vinblastine—head and neck cancer	0.0004	0.0036	CcSEcCtD
Melphalan—Pain—Vinblastine—head and neck cancer	0.000394	0.00354	CcSEcCtD
Melphalan—Arrhythmia—Fluorouracil—head and neck cancer	0.00038	0.00342	CcSEcCtD
Melphalan—Bronchospasm—Docetaxel—head and neck cancer	0.000377	0.00339	CcSEcCtD
Melphalan—Alopecia—Fluorouracil—head and neck cancer	0.000376	0.00338	CcSEcCtD
Melphalan—Dyspnoea—Hydroxyurea—head and neck cancer	0.000374	0.00337	CcSEcCtD
Melphalan—Dyspepsia—Hydroxyurea—head and neck cancer	0.00037	0.00332	CcSEcCtD
Melphalan—Decreased appetite—Hydroxyurea—head and neck cancer	0.000365	0.00328	CcSEcCtD
Melphalan—Pancytopenia—Docetaxel—head and neck cancer	0.000364	0.00328	CcSEcCtD
Melphalan—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000363	0.00326	CcSEcCtD
Melphalan—Fatigue—Hydroxyurea—head and neck cancer	0.000362	0.00325	CcSEcCtD
Melphalan—Pain—Hydroxyurea—head and neck cancer	0.000359	0.00323	CcSEcCtD
Melphalan—Neutropenia—Docetaxel—head and neck cancer	0.000359	0.00323	CcSEcCtD
Melphalan—Ibuprofen—PTGS2—head and neck cancer	0.00035	0.19	CrCbGaD
Melphalan—Anaemia—Fluorouracil—head and neck cancer	0.000342	0.00308	CcSEcCtD
Melphalan—Hypersensitivity—Vinblastine—head and neck cancer	0.000339	0.00305	CcSEcCtD
Melphalan—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000335	0.00301	CcSEcCtD
Melphalan—Stomatitis—Docetaxel—head and neck cancer	0.000333	0.003	CcSEcCtD
Melphalan—Jaundice—Docetaxel—head and neck cancer	0.000333	0.003	CcSEcCtD
Melphalan—Leukopenia—Fluorouracil—head and neck cancer	0.000332	0.00298	CcSEcCtD
Melphalan—Asthenia—Vinblastine—head and neck cancer	0.00033	0.00297	CcSEcCtD
Melphalan—SLC22A3—lymph node—head and neck cancer	0.000326	0.0198	CbGeAlD
Melphalan—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000323	0.00291	CcSEcCtD
Melphalan—Convulsion—Fluorouracil—head and neck cancer	0.000321	0.00288	CcSEcCtD
Melphalan—Myalgia—Fluorouracil—head and neck cancer	0.000315	0.00283	CcSEcCtD
Melphalan—Chest pain—Fluorouracil—head and neck cancer	0.000315	0.00283	CcSEcCtD
Melphalan—Diarrhoea—Vinblastine—head and neck cancer	0.000315	0.00283	CcSEcCtD
Melphalan—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000309	0.00278	CcSEcCtD
Melphalan—Haemoglobin—Docetaxel—head and neck cancer	0.000309	0.00277	CcSEcCtD
Melphalan—Haemorrhage—Docetaxel—head and neck cancer	0.000307	0.00276	CcSEcCtD
Melphalan—Hepatitis—Docetaxel—head and neck cancer	0.000307	0.00276	CcSEcCtD
Melphalan—Urinary tract disorder—Docetaxel—head and neck cancer	0.000303	0.00273	CcSEcCtD
Melphalan—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000302	0.00272	CcSEcCtD
Melphalan—Oedema—Fluorouracil—head and neck cancer	0.000302	0.00272	CcSEcCtD
Melphalan—Connective tissue disorder—Docetaxel—head and neck cancer	0.000302	0.00271	CcSEcCtD
Melphalan—Asthenia—Hydroxyurea—head and neck cancer	0.000301	0.00271	CcSEcCtD
Melphalan—Urethral disorder—Docetaxel—head and neck cancer	0.000301	0.00271	CcSEcCtD
Melphalan—Infection—Fluorouracil—head and neck cancer	0.0003	0.0027	CcSEcCtD
Melphalan—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000296	0.00266	CcSEcCtD
Melphalan—Tachycardia—Fluorouracil—head and neck cancer	0.000295	0.00265	CcSEcCtD
Melphalan—Vomiting—Vinblastine—head and neck cancer	0.000293	0.00263	CcSEcCtD
Melphalan—Anorexia—Fluorouracil—head and neck cancer	0.000288	0.00259	CcSEcCtD
Melphalan—Diarrhoea—Hydroxyurea—head and neck cancer	0.000287	0.00258	CcSEcCtD
Melphalan—Flushing—Docetaxel—head and neck cancer	0.000285	0.00256	CcSEcCtD
Melphalan—Hypotension—Fluorouracil—head and neck cancer	0.000282	0.00254	CcSEcCtD
Melphalan—Immune system disorder—Docetaxel—head and neck cancer	0.000277	0.00249	CcSEcCtD
Melphalan—Mediastinal disorder—Docetaxel—head and neck cancer	0.000277	0.00249	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000275	0.00248	CcSEcCtD
Melphalan—Arrhythmia—Docetaxel—head and neck cancer	0.000274	0.00247	CcSEcCtD
Melphalan—Nausea—Vinblastine—head and neck cancer	0.000274	0.00246	CcSEcCtD
Melphalan—Paraesthesia—Fluorouracil—head and neck cancer	0.000271	0.00244	CcSEcCtD
Melphalan—Alopecia—Docetaxel—head and neck cancer	0.000271	0.00244	CcSEcCtD
Melphalan—Dyspnoea—Fluorouracil—head and neck cancer	0.000269	0.00242	CcSEcCtD
Melphalan—Vomiting—Hydroxyurea—head and neck cancer	0.000267	0.0024	CcSEcCtD
Melphalan—Dyspepsia—Fluorouracil—head and neck cancer	0.000266	0.00239	CcSEcCtD
Melphalan—Rash—Hydroxyurea—head and neck cancer	0.000265	0.00238	CcSEcCtD
Melphalan—Dermatitis—Hydroxyurea—head and neck cancer	0.000265	0.00238	CcSEcCtD
Melphalan—Decreased appetite—Fluorouracil—head and neck cancer	0.000263	0.00236	CcSEcCtD
Melphalan—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000261	0.00235	CcSEcCtD
Melphalan—Pain—Fluorouracil—head and neck cancer	0.000258	0.00232	CcSEcCtD
Melphalan—Nausea—Hydroxyurea—head and neck cancer	0.000249	0.00224	CcSEcCtD
Melphalan—Anaemia—Docetaxel—head and neck cancer	0.000247	0.00222	CcSEcCtD
Melphalan—Urticaria—Fluorouracil—head and neck cancer	0.00024	0.00216	CcSEcCtD
Melphalan—Leukopenia—Docetaxel—head and neck cancer	0.000239	0.00215	CcSEcCtD
Melphalan—Cough—Docetaxel—head and neck cancer	0.000233	0.0021	CcSEcCtD
Melphalan—Convulsion—Docetaxel—head and neck cancer	0.000232	0.00208	CcSEcCtD
Melphalan—Myalgia—Docetaxel—head and neck cancer	0.000228	0.00205	CcSEcCtD
Melphalan—Chest pain—Docetaxel—head and neck cancer	0.000228	0.00205	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000226	0.00203	CcSEcCtD
Melphalan—Hypersensitivity—Fluorouracil—head and neck cancer	0.000223	0.002	CcSEcCtD
Melphalan—Anaphylactic shock—Docetaxel—head and neck cancer	0.000218	0.00196	CcSEcCtD
Melphalan—Oedema—Docetaxel—head and neck cancer	0.000218	0.00196	CcSEcCtD
Melphalan—Infection—Docetaxel—head and neck cancer	0.000217	0.00195	CcSEcCtD
Melphalan—Pruritus—Fluorouracil—head and neck cancer	0.000214	0.00192	CcSEcCtD
Melphalan—Thrombocytopenia—Docetaxel—head and neck cancer	0.000214	0.00192	CcSEcCtD
Melphalan—Tachycardia—Docetaxel—head and neck cancer	0.000213	0.00191	CcSEcCtD
Melphalan—Skin disorder—Docetaxel—head and neck cancer	0.000212	0.00191	CcSEcCtD
Melphalan—Anorexia—Docetaxel—head and neck cancer	0.000208	0.00187	CcSEcCtD
Melphalan—Diarrhoea—Fluorouracil—head and neck cancer	0.000207	0.00186	CcSEcCtD
Melphalan—Hypotension—Docetaxel—head and neck cancer	0.000204	0.00183	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000199	0.00179	CcSEcCtD
Melphalan—Paraesthesia—Docetaxel—head and neck cancer	0.000196	0.00176	CcSEcCtD
Melphalan—Dyspnoea—Docetaxel—head and neck cancer	0.000194	0.00175	CcSEcCtD
Melphalan—Vomiting—Fluorouracil—head and neck cancer	0.000192	0.00173	CcSEcCtD
Melphalan—Dyspepsia—Docetaxel—head and neck cancer	0.000192	0.00173	CcSEcCtD
Melphalan—Rash—Fluorouracil—head and neck cancer	0.000191	0.00171	CcSEcCtD
Melphalan—Dermatitis—Fluorouracil—head and neck cancer	0.00019	0.00171	CcSEcCtD
Melphalan—Decreased appetite—Docetaxel—head and neck cancer	0.00019	0.0017	CcSEcCtD
Melphalan—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000188	0.00169	CcSEcCtD
Melphalan—Fatigue—Docetaxel—head and neck cancer	0.000188	0.00169	CcSEcCtD
Melphalan—Pain—Docetaxel—head and neck cancer	0.000187	0.00168	CcSEcCtD
Melphalan—Nausea—Fluorouracil—head and neck cancer	0.00018	0.00161	CcSEcCtD
Melphalan—Hypersensitivity—Docetaxel—head and neck cancer	0.000161	0.00144	CcSEcCtD
Melphalan—Asthenia—Docetaxel—head and neck cancer	0.000157	0.00141	CcSEcCtD
Melphalan—Pruritus—Docetaxel—head and neck cancer	0.000154	0.00139	CcSEcCtD
Melphalan—Diarrhoea—Docetaxel—head and neck cancer	0.000149	0.00134	CcSEcCtD
Melphalan—Vomiting—Docetaxel—head and neck cancer	0.000139	0.00125	CcSEcCtD
Melphalan—Rash—Docetaxel—head and neck cancer	0.000138	0.00124	CcSEcCtD
Melphalan—Dermatitis—Docetaxel—head and neck cancer	0.000137	0.00124	CcSEcCtD
Melphalan—Nausea—Docetaxel—head and neck cancer	0.00013	0.00116	CcSEcCtD
